Local Immunological Effect of Neoadjuvant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Cancer

被引：0
|
作者：
Murakami, T. [1 ]
Mori, R. [1 ]
Matsuyama, R. [1 ]
Homma, Y. [1 ]
Nakazawa, M. [2 ]
Tanaka, Y. [1 ]
Miyake, K. [1 ]
Sawada, Y. [1 ]
Oota, Y. [1 ]
Hiroshima, Y. [1 ]
Kumamoto, T. [1 ]
Ueda, M. [1 ]
Takeda, K. [1 ]
Ichikawa, Y. [1 ]
Tanaka, K. [1 ]
Endo, I. [1 ]
机构：
[1] Yokohama City Univ, Grad Sch Med, Dept Surg Gastroenterol, Yokohama, Kanagawa 232, Japan
[2] Yokohama City Univ, Grad Sch Med, Dept Expt Anim Med, Yokohama, Kanagawa 232, Japan
来源：
PANCREAS | 2014年 / 43卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
下载
收藏
页码：1394 / 1394
页数：1
相关论文
共 50 条
  • [31] Immunological Effect of Neoadjuvant Chemoradiotherapy on Tumor Microenvironment of Pancreatic Cancer
    Homma, Y.
    Taniguchi, K.
    Matsuyama, R.
    Murakami, T.
    Nakagawa, K.
    Mori, R.
    Nojiri, K.
    Kumamoto, T.
    Ueda, M.
    Takeda, K.
    Ichikawa, Y.
    Tanaka, K.
    Endo, I.
    [J]. PANCREAS, 2012, 41 (07) : 1154 - 1154
  • [32] Clinical Impact of Neoadjuvant Chemotherapy and Chemoradiotherapy in Borderline Resectable Pancreatic Cancer: Analysis of 884 Patients at Facilities Specializing in Pancreatic Surgery
    Nagakawa, Yuichi
    Sahara, Yatsuka
    Hosokawa, Yuichi
    Murakami, Yoshiaki
    Yamaue, Hiroki
    Satoi, Sohei
    Unno, Michiaki
    Isaji, Shuji
    Endo, Itaru
    Sho, Masayuki
    Fujii, Tsutomu
    Takishita, Chie
    Hijikata, Yosuke
    Suzuki, Shuji
    Kawachi, Shigeyuki
    Katsumata, Kenji
    Ohta, Tetsuo
    Nagakawa, Takukazu
    Tsuchida, Akihiko
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (06) : 1629 - 1636
  • [33] Clinical Impact of Neoadjuvant Chemotherapy and Chemoradiotherapy in Borderline Resectable Pancreatic Cancer: Analysis of 884 Patients at Facilities Specializing in Pancreatic Surgery
    Yuichi Nagakawa
    Yatsuka Sahara
    Yuichi Hosokawa
    Yoshiaki Murakami
    Hiroki Yamaue
    Sohei Satoi
    Michiaki Unno
    Shuji Isaji
    Itaru Endo
    Masayuki Sho
    Tsutomu Fujii
    Chie Takishita
    Yosuke Hijikata
    Shuji Suzuki
    Shigeyuki Kawachi
    Kenji Katsumata
    Tetsuo Ohta
    Takukazu Nagakawa
    Akihiko Tsuchida
    [J]. Annals of Surgical Oncology, 2019, 26 : 1629 - 1636
  • [34] Margin Status and Neoadjuvant Chemoradiation in Patients with Borderline Resectable Pancreatic Cancer
    Papavasiliou, P.
    Piposar, J. R.
    Arrangoiz, R.
    Chen, K. T.
    Zhu, F.
    Chun, Y.
    Hoffman, P.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S157 - S157
  • [35] Outcomes of Neoadjuvant Concurrent Chemoradiotherapy in Borderline Resectable Pancreatic Cancer at a Sydney Tertiary Referral Center
    Fox, W.
    Tse, R.
    Shameem, N.
    Beale, P.
    Hruby, G.
    Sandroussi, C.
    Grimison, P.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 58 - 59
  • [36] Margin status and neoadjuvant chemoradiation in patients with borderline resectable pancreatic cancer
    Papavasiliou, Pavlos
    Piposar, Jonathan R.
    Arrangoiz, Rodrigo
    Chen, Kathryn T.
    Zhu, Fang
    Chun, Yun Shin
    Hoffman, John Parker
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [37] Survival benefit of neoadjuvant FOLFIRINOX for patients with borderline resectable pancreatic cancer
    Waugh, Evelyn
    Glinka, Juan
    Breadner, Daniel
    Liu, Rachel
    Tang, Ephraim
    Allen, Laura
    Welch, Stephen
    Leslie, Ken
    Skaro, Anton
    [J]. ANNALS OF HEPATO-BILIARY-PANCREATIC SURGERY, 2024, 28 (02) : 229 - 237
  • [38] Perioperative Chemotherapy and Chemoradiotherapy for Patients With Resectable and Borderline Resectable Pancreatic Adenocarcinoma
    Coveler, Andrew L.
    Pillarisetty, Venu G.
    Koh, Wui-Jin
    Zhen, David B.
    Park, James O.
    King, Gentry G.
    Sham, Jonathan G.
    Hannan, Lindsay M.
    Mann, Gary N.
    Baker, Kelsey K.
    Redman, Mary W.
    Swanson, Paul E.
    Chiorean, E. Gabriela
    Whiting, Sam H.
    [J]. PANCREAS, 2023, 52 (05) : E282 - E287
  • [39] Neoadjuvant Gemcitabine-based Accelerated Hyperfractionation Chemoradiotherapy for Patients with Borderline Resectable Pancreatic Adenocarcinoma
    Takeda, Yutaka
    Nakamori, Shoji
    Eguchi, Hidetoshi
    Kobayashi, Shogo
    Marubashi, Shigeru
    Tanemura, Masahiro
    Konishi, Koji
    Yoshioka, Yasuo
    Umeshita, Koji
    Mori, Masaki
    Doki, Yuichiro
    Nagano, Hiroaki
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (12) : 1172 - 1180
  • [40] The Role of Neoadjuvant Chemoradiotherapy for Potentially Resectable Pancreatic Cancer
    Kim, Yoon Jae
    Choi, Jin-Young
    Chung, Yong Eun
    Kim, Hee Man
    Park, Semi
    Kim, Hong Jeoung
    Hong, Sung Pil
    Seong, Jinsil
    Park, Seung Woo
    Chung, Jae Bock
    Song, Si Young
    Bang, Seungmin
    [J]. GASTROENTEROLOGY, 2009, 136 (05) : A314 - A314
12345